论文部分内容阅读
目的:分析头孢哌酮钠舒巴坦钠治疗糖尿病合并泌尿系统感染的治疗效果及不良反应。方法:随机抽取78例糖尿病合并泌尿系统感染患者作为研究对象,按治疗方法的不同,分为对照组(39例)和观察组(39例),对照组给予左氧氟沙星治疗,观察组给予头孢哌酮钠舒巴坦钠治疗,记录比较两组患者的不良反应。结果:观察组有效率显著高于对照组(P<0.05);观察组不良反应发生率明显低于对照组(P<0.05)。结论:糖尿病合并泌尿系统感染患者采取头孢哌酮钠舒巴坦钠治疗的临床效果显著,且用药安全性好,值得临床推广使用。
Objective: To analyze the therapeutic effect and adverse reactions of cefoperazone sodium and sulbactam sodium in the treatment of diabetic patients with urinary tract infection. Methods: Seventy-eight patients with diabetes mellitus and urinary tract infection were randomly divided into control group (39 cases) and observation group (39 cases). The control group was treated with levofloxacin, and the observation group was given cefoperazone sodium and sulbactam Sodium treatment, record the adverse reactions of two groups of patients. Results: The effective rate in the observation group was significantly higher than that in the control group (P <0.05). The incidence of adverse reactions in the observation group was significantly lower than that in the control group (P <0.05). Conclusion: The clinical efficacy of cefoperazone sodium and sulbactam sodium in patients with diabetes mellitus and urinary tract infection is significant, and the medication is safe and worthy of clinical promotion.